Blog


A Decade of Proving Critics Wrong

July 27, 2016

As it was enacted into law in 2003, the Medicare prescription drug benefit, which would come to be known as Medicare Part D, had no shortage of critics.  A New … Continued


An Innovation-Centric Approach to Pricing and Accessibility

July 7, 2016

“Policy should not lose sight of the fact that new treatments represent miracles to many patients, and should encourage more, not less innovation.” With those words in her op-ed in … Continued


The Trustees Report and the Need for Action

June 22, 2016

On a day in which the House Republicans are announcing their alternative health reform plan, House Democrats are staging a sit-in over gun laws, and the presumptive presidential nominees are … Continued


Utilizing Technology to Propel Precision Medicine Forward

April 4, 2016

As we’ve seen, there has been a steadily increasing level of discussion and enthusiasm surrounding precision medicine.  The Healthcare Leadership Council (HLC) has remained engaged in this conversation, given the … Continued


Medicare Embraces the ‘Ounce of Prevention’ Philosophy

March 23, 2016

We’ve long maintained that Medicare can be a stronger program, both in terms of protecting the health of its beneficiaries and in improved cost-efficiency, if it did a better job … Continued


The Amazing, Classy, Winning (and Completely Ridiculous) $300 Billion Proposal

February 19, 2016

It’s a notion we’ve heard a fair amount during the presidential campaign, this idea that Medicare should ‘negotiate’ prescription drug prices.  (There’s a very good reason I put ‘negotiate’ in … Continued


Bringing Value to the Patient and the Healthcare System: A New Report

February 4, 2016

This week the Patient-Centered Primary Care Collaborative (PCPCC) unveiled its fifth annual report on the patient centered medical home’s (PCMH) impact on cost and quality.  In the quest to improve … Continued


What to Expect in 2016, From an Industry Leader

January 6, 2016

In these early days of the new year, all eyes will be on the U.S. House as it prepares to pass legislation repealing the Affordable Care Act, which will go … Continued


He’s Not a Pharmaceutical CEO

December 18, 2015

In the movie Wall Street, the amoral corporate takeover specialist Gordon Gekko is intent on taking over the fictional airline company BlueStar so he can break it up into pieces … Continued


The Proliferation of Progress Generated by Medicare Advantage

December 11, 2015

This week the Blue Cross Blue Shield Association, representing plans that serve over four million individuals in Medicare Advantage and Medicare Part D prescription drug plans, hosted a congressional briefing … Continued